We are live on ! Find out more
NSAA

Noroian Steven A & Associates Portfolio holdings

AUM $29.6M
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+21.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$29.6M
AUM Growth
+$713K
Cap. Flow
+$59.1K
Cap. Flow %
0.2%
Top 10 Hldgs %
52.55%
Holding
24
New
1
Increased
1
Reduced
12
Closed

Top Buys

Rank Stock Value
1
PCG icon
PG&E
PCG
+$208K
2
SYK icon
Stryker
SYK
+$9.94K

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$32.6K
2
CTSH icon
Cognizant
CTSH
+$30K
3
ACN icon
Accenture
ACN
+$24.6K
4
COP icon
ConocoPhillips
COP
+$20.1K
5
VAR
Varian Medical Systems, Inc.
VAR
+$12.3K

Sector Composition

Rank Sector Weight
1 Healthcare 22.65%
2 Energy 20.71%
3 Technology 18.66%
4 Industrials 15.53%
5 Consumer Staples 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
1
Cognizant
CTSH
$24.9B
$1.83M 6.18%
36,100
-600
-2% -$30K
FLS icon
2
Flowserve
FLS
$9.71B
$1.74M 5.88%
22,196
-125
-0.6% -$9.59K
WAT icon
3
Waters Corp
WAT
$37B
$1.71M 5.77%
15,758
-100
-0.6% -$10.8K
CERN
4
DELISTED
Cerner Corp
CERN
$1.68M 5.68%
29,884
EOG icon
5
EOG Resources
EOG
$79.2B
$1.56M 5.29%
15,950
SRCL
6
DELISTED
Stericycle Inc
SRCL
$1.52M 5.13%
13,364
VAR
7
DELISTED
Varian Medical Systems, Inc.
VAR
$1.43M 4.85%
19,467
-171
-0.9% -$12.3K
JNJ icon
8
Johnson & Johnson
JNJ
$618B
$1.4M 4.73%
14,227
-25
-0.2% -$2.32K
SLB icon
9
SLB Ltd
SLB
$73.6B
$1.34M 4.53%
13,741
-25
-0.2% -$2.26K
CNI icon
10
Canadian National Railway
CNI
$76.9B
$1.34M 4.52%
23,788
ACN icon
11
Accenture
ACN
$102B
$1.3M 4.4%
16,317
-300
-2% -$24.6K
EMC
12
DELISTED
EMC CORPORATION
EMC
$1.29M 4.35%
46,904
SYK icon
13
Stryker
SYK
$125B
$1.27M 4.29%
15,889
+125
+0.8% +$9.94K
LH icon
14
Labcorp
LH
$25B
$1.26M 4.28%
14,996
-116
-0.8% -$9.25K
XOM icon
15
ExxonMobil
XOM
$644B
$1.26M 4.26%
12,889
-24
-0.2% -$2.29K
CVX icon
16
Chevron
CVX
$392B
$1.14M 3.84%
9,560
PRU icon
17
Prudential Financial
PRU
$42.4B
$1.13M 3.81%
13,323
-25
-0.2% -$2.15K
MSFT icon
18
Microsoft
MSFT
$3.45T
$1.11M 3.74%
27,013
RMD icon
19
ResMed
RMD
$30.6B
$1.06M 3.59%
23,750
TGT icon
20
Target
TGT
$65.6B
$1.02M 3.45%
16,869
-550
-3% -$32.6K
MNST icon
21
Monster Beverage
MNST
$94.3B
$956K 3.23%
82,590
COP icon
22
ConocoPhillips
COP
$147B
$826K 2.79%
11,748
-300
-2% -$20.1K
PCG icon
23
PG&E
PCG
$38.3B
$211K 0.71%
+4,892
New +$208K
PG icon
24
Procter & Gamble
PG
$336B
$210K 0.71%
2,601

Similar funds

Noroian Steven A & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Noroian Steven A & Associates held 24 positions worth $29.6M, up 2.5% from $28.9M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Trading was light in Q1 2014: portfolio turnover was 4.2%. Noroian Steven A & Associates opened 1 new position and made no exits, leaving the 24-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Energy and Technology.

  • Noroian Steven A & Associates's largest Q1 2014 buy was PG&E: 4,892 shares worth $211K.
  • Noroian Steven A & Associates added most to Stryker in Q1 2014, an estimated $9.94K increase.
  • Noroian Steven A & Associates's biggest Q1 2014 reduction was Target, cutting an estimated $32.6K.
  • Noroian Steven A & Associates's ten largest holdings make up 53% of its $29.6M portfolio in Q1 2014.
  • Noroian Steven A & Associates opened 1 new position and closed 0 in Q1 2014.
  • Noroian Steven A & Associates's portfolio value rose 2.5% quarter-over-quarter to $29.6M.

Based on Noroian Steven A & Associates's 13F filing for Q1 2014, filed 13 May 2014.